BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24780757)

  • 1. Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15.
    Bruzzese F; Hägglöf C; Leone A; Sjöberg E; Roca MS; Kiflemariam S; Sjöblom T; Hammarsten P; Egevad L; Bergh A; Ostman A; Budillon A; Augsten M
    Cancer Res; 2014 Jul; 74(13):3408-17. PubMed ID: 24780757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of growth differentiation factor-15 restrains prostate cancer through regulating MAPK/ERK signaling pathway.
    Yang M; Guo M; Su C; Hao W; Xu Z
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):162-167. PubMed ID: 38650142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer.
    Owen JS; Clayton A; Pearson HB
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal-derived MAOB promotes prostate cancer growth and progression.
    Pu T; Wang J; Wei J; Zeng A; Zhang J; Chen J; Yin L; Li J; Lin TP; Melamed J; Corey E; Gao AC; Wu BJ
    Sci Adv; 2024 Feb; 10(6):eadi4935. PubMed ID: 38335292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.
    Chang C; Cheng YY; Kamlapurkar S; White S; Tang PW; Elhaw AT; Javed Z; Aird KM; Mythreye K; Phaëton R; Hempel N
    Gynecol Oncol; 2024 Jun; 185():8-16. PubMed ID: 38342006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction decreases cisplatin sensitivity in gastric cancer cells through upregulation of integrated stress response and mitokine GDF15.
    Wang SF; Chang YL; Liu TY; Huang KH; Fang WL; Li AF; Yeh TS; Hung GY; Lee HC
    FEBS J; 2024 Mar; 291(6):1131-1150. PubMed ID: 37935441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction and cisplatin sensitivity in gastric cancer: GDF15 as a master player.
    Cavinato M
    FEBS J; 2024 Mar; 291(6):1111-1114. PubMed ID: 38348639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDF15 as a key disease target and biomarker: linking chronic lung diseases and ageing.
    Wan Y; Fu J
    Mol Cell Biochem; 2024 Mar; 479(3):453-466. PubMed ID: 37093513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways.
    Urakawa N; Utsunomiya S; Nishio M; Shigeoka M; Takase N; Arai N; Kakeji Y; Koma Y; Yokozaki H
    Lab Invest; 2015 May; 95(5):491-503. PubMed ID: 25730371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis.
    Meier JC; Haendler B; Seidel H; Groth P; Adams R; Ziegelbauer K; Kreft B; Beckmann G; Sommer A; Kopitz C
    Cancer Med; 2015 Feb; 4(2):253-67. PubMed ID: 25490861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent.
    Alkasalias T; Flaberg E; Kashuba V; Alexeyenko A; Pavlova T; Savchenko A; Szekely L; Klein G; Guven H
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17188-93. PubMed ID: 25404301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of osteoclastogenesis by osteocytes through growth differentiation factor-15].
    Hinoi E
    Yakugaku Zasshi; 2014; 134(12):1259-63. PubMed ID: 25452236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAG-1/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway.
    Min KW; Liggett JL; Silva G; Wu WW; Wang R; Shen RF; Eling TE; Baek SJ
    Oncogene; 2016 Jan; 35(3):377-88. PubMed ID: 25893289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation.
    Ishige T; Nishimura M; Satoh M; Fujimoto M; Fukuyo M; Semba T; Kado S; Tsuchida S; Sawai S; Matsushita K; Togawa A; Matsubara H; Kaneda A; Nomura F
    Sci Rep; 2016 Feb; 6():21681. PubMed ID: 26892343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts are associated with poor prognosis in esophageal squamous cell carcinoma after surgery.
    Cheng Y; Wang K; Ma W; Zhang X; Song Y; Wang J; Wang N; Song Q; Cao F; Tan B; Yu J
    Int J Clin Exp Med; 2015; 8(2):1896-903. PubMed ID: 25932118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone mice.
    Husaini Y; Lockwood GP; Nguyen TV; Tsai VW; Mohammad MG; Russell PJ; Brown DA; Breit SN
    PLoS One; 2015; 10(2):e0115189. PubMed ID: 25695521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment.
    Lee YC; Gajdosik MS; Josic D; Clifton JG; Logothetis C; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
    Mol Cell Proteomics; 2015 Mar; 14(3):471-83. PubMed ID: 25527621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases.
    Fujita Y; Ito M; Kojima T; Yatsuga S; Koga Y; Tanaka M
    Mitochondrion; 2015 Jan; 20():34-42. PubMed ID: 25446397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is GDF15 beneficial to erythropoiesis in low grade myelodysplastic syndrome?
    O'Toole D; Kennedy P; Quinn J; Murphy PT
    Leuk Lymphoma; 2015 Jun; 56(6):1914-5. PubMed ID: 25347430
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate.
    Lambert JR; Whitson RJ; Iczkowski KA; La Rosa FG; Smith ML; Wilson RS; Smith EE; Torkko KC; Gari HH; Lucia MS
    Prostate; 2015 Feb; 75(3):255-65. PubMed ID: 25327758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.